Click to Skip Ad
Closing in...


Coronavirus Vaccine Oxford

Only a ‘small chance’ a promising coronavirus vaccine is ready by Christmas

November 4th, 2020

The first coronavirus vaccine results might be ready in the coming weeks, but there’s no guarantee that immunization campaigns can start by Christmas. Oxford professor Andrew Pollard, a leading researcher on the promising COVID-19 vaccine developed with AstraZeneca, told UK Parliament that there’s only a “small chance” the drug is ready by Christmas. The UK …

Coronavirus Vaccine Update

These promising coronavirus vaccines could be approved sooner than expected – but not in the US

November 1st, 2020

The UK has accelerated the review of the three coronavirus vaccine frontrunners: AstraZeneca, Moderna, and Pfizer. The country’s government is conducting rolling reviews, which allow it to see data in real-time and potentially hasten emergency use approval for the vaccine candidates that prove to be safe and effective. The US FDA has strict requirements for …

Coronavirus Vaccine

Oxford coronavirus vaccine trial results are ‘extremely encouraging’

July 21st, 2020

The coronavirus vaccine update we’ve been waiting for is finally here, as Oxford published the research for the Phase 1/2 clinical trial of its experimental drug. As previously detailed, the drug induces a dual immune response in volunteers that includes the production of neutralizing antibodies that bind to the spike protein of the virus and …

Coronavirus Vaccine

Get ready for some fantastic news about a coronavirus vaccine

July 16th, 2020

The Oxford vaccine delivers “double defense” against the novel coronavirus, sources familiar with the matter revealed. Oxford’s team will soon publish the results of its Phase 1 trial. The data will indicate the experimental COVID-19 drug is safe and that it can elicit a promising immune response that includes the production of neutralizing antibodies and …

Coronavirus Vaccine Trials

One vaccine maker is thinking about intentionally exposing volunteers to the coronavirus

May 31st, 2020

Coronavirus vaccine trials have hit a serious snag, as there aren’t enough COVID-19 patients in the communities where volunteers might reside. If not enough people get sick, researchers can’t assess the effectiveness of the vaccine candidate. AstraZeneca, which will produce the promising Oxford vaccine, confirmed that it’s considering challenge trials where subjects are exposed to …